Article Details

Sanofi to acquire Dren Bio's bispecific myeloid cell engager for deep B-cell depletion ...

Retrieved on: 2025-03-20 13:24:10

Tags for this article:

Click the tags to see associated articles and topics

Sanofi to acquire Dren Bio's bispecific myeloid cell engager for deep B-cell depletion .... View article details on hiswai:

Excerpt

Dren Bio deep B-cell depleter program has the potential to reset the immune system; Acquisition underpins path for Sanofi becoming leading immunology ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo